Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 166 (1) , 238-244
- https://doi.org/10.1016/0006-291x(90)91936-m
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- MPP+-induced pathophysiology demonstrates advantages of neurotoxicology studies in brain slicesJournal of Neuroscience Methods, 1989
- Mechanisms underlying neuronal degeneration in Parkinson's disease: An experimental and theoretical treatiseMovement Disorders, 1989
- Interaction of 1-methyl-4-phenylpyridinium ion with human plateletsBiochemical and Biophysical Research Communications, 1988
- MPTP Toxicity: Implications for Research in Parkinson's DiseaseAnnual Review of Neuroscience, 1988
- Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP), cyperquat (MPP+) and paraquat on isolated mitochondria from rat striatum, cortex and liverLife Sciences, 1988
- Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytesChemico-Biological Interactions, 1987
- Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonismBiochemical and Biophysical Research Communications, 1986
- 1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in cultureNeuroscience Letters, 1985
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984